We're launching Sleuth today. The intelligence platform for biopharma's highest-stakes decisions, in use at top companies in the world. To celebrate, we broke down the Chinese landscape: 18K+ assets & a map of the strategic white space. RT + comment "Sleuth" for access. t.co/QOx48Pc95D

- Views
- 451,457
- Likes
- 259
- Replies
- 166
- Reposts
- 62
- Quotes
- 8
- Bookmarks
- 174
We're launching Sleuth today.
Sleuth is introduced as an intelligence platform for high-stakes biopharma decisions. It maps drug programs, mechanisms, competitors, clinical data, deals, and internal data, with a launch focus on the Chinese biopharma pipeline and strategic opportunities through 2026.
- Views
- 451.5K
- Likes
- 259
- Replies
- 166
- Reposts
- 62
- Quotes
- 8
- Bookmarks
- 174
- Topics
Analysis
Sleuth is introduced as an intelligence platform for high-stakes biopharma decisions. It maps drug programs, mechanisms, competitors, clinical data, deals, and internal data, with a launch focus on the Chinese biopharma pipeline and strategic opportunities through 2026.
Sign in to see the full analysis.
Sign inVisual hook
We're launching Sleuth today.
- 01The Announcement
Open with a direct announcement that a new product, project, or offering is now available.
- 02The Positioning
Explain what the offering is for and add credibility by showing who uses it or why it matters.
- 03The Access CTA
Share a useful launch asset, add a concrete proof point, and tell readers how to request access.
